HPV can cause several types of cancer:

By the numbers:

xx

Vaccination Disparities:

Audience: This webinar is for medical providers, those who serve and their families, HPV prevention advocates, and those who provide care or services to military or veteran populations.

Objectives: Attendees will learn about:

• HPV and its connection to HPV-related cancers.
• The HPV vaccination and cancer rates among military and veterans, particularly compared to the civilian population.
• The impact on individuals who serve and overall military readiness.
• About successful strategies for HPV-related cancer prevention including screening, vaccination, and provider education.

xx

WATCH THE RECORDING on our YouTube Channel:

HPV is the most preventable cause of cancer. The vaccine is covered by TRICARE. And yet vaccination rates among those who serve are half the national average.

Get a Reminder Text!

You are busy. Let us help you remember your health!

We can send you a text message (regular text/data charges may apply) to remind you to schedule your next HPV/Cancer screening. This can be particularly helpful when you are transferred or deployed. Staying on top of your cancer screenings keeps you healthy and mission-ready. Click the link below to sign up for reminders.

Get a Reminder Text Here or click the picture below!

Read the cancer story of Cemonia, a military spouse.

Cemonia's story of battling cervical cancer caused by HPV is inspiring. Her story is a reminder that HPV doesn't only affect those who serve.

Click the image below to read Cermonia's story, and find more stories like hers at Cervivor.org/stories.

Download this poster for your office:

Download this provider fact sheet:

Quick-reference handout on HPV prevalence in the military, vaccination schedules, and the announcement approach to recommending the vaccine.

xx

xx

Watch this video on how to recommend the HPV vaccine in a military setting.

YouTube Video Link

xx

xx

xx

xx

xx

xx

xx

Watch this webinar on HPV prevention in the military.

Link to Watch Webinar

• HPV-Related Cancers: A Growing Threat to U.S. Military Health and Readiness. Julia Seay, Rayna Matsuno, Jennifer Buechel, Karen Tannenbaum, Natalie Wells. Military Medicine. May/June 2022.

• Feasibility and sustainability of a nurse-led intervention to integrate HPV vaccination into medical processing for active-duty Soldiers. Penick E, Grabert BK, Stockton E, Prentice-Dunn H, Ward M, Kirk T, Gilkey MB. Hum Vaccin Immunother. 2022 Dec 30

• Human Papillomavirus Vaccination Prevalence and Disproportionate Cancer Burden Among US Veterans. Chidambaram S, Chang SH, Sandulache VC, Mazul AL, Zevallos JP. JAMA Oncol. 2023 May

• Factors Associated with Human Papillomavirus Vaccine Initiation and Compliance Among U.S. Military Service Members. Rayna K Matsuno, Julia Seay, Ben Porter, Karen Tannenbaum, Steven Warner, Natalie Wells, Military Medicine, July/August 2023.

• Federal Practioner, Data Trends. July 2023. www.fedprac-digital.com/federalpractitioner/federal_health_care_data_trends_2023/MobilePagedReplica.action?pm=2&folio=Cover#pg1

• National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System. Zevallos JP, Kramer JR, Sandulache VC, Massa ST, Hartman CM, Mazul AL, Wahle BM, Gerndt SP, Sturgis EM, Chiao EY. Head Neck. Jan 2021.

• Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System. Daly CM, Hansen SL, Kwon PO, Roberts TA. J Community Health. 2018 Jun.

• Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans. Mazul AL, Hartman CM, Mowery YM, Kramer JR, White DL, Royse KE, Raychaudhury S, Sandulache VC, Ahmed ST, Zevallos JP, Richardson PA, Sikora AG, Chiao EY. Cancer. 2022 Sep 15.

• Clinical and economic burden of HPV-related cancers in the US veteran population. Saxena K, Dawson RS, Cyhaniuk A, Bello T, Janjan N. J Med Econ. 2022 Jan-Dec.

• Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine. Nsouli-Maktabi H, Ludwig SL, Yerubandi UD, Gaydos JC. MSMR. 2013 Feb.